22-29060486-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015370.2(C22orf31):āc.361A>Gā(p.Lys121Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000889 in 1,461,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015370.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C22orf31 | NM_015370.2 | c.361A>G | p.Lys121Glu | missense_variant | 2/3 | ENST00000216071.5 | NP_056185.1 | |
C22orf31 | NM_001386866.1 | c.238A>G | p.Lys80Glu | missense_variant | 2/3 | NP_001373795.1 | ||
C22orf31 | XM_017028741.2 | c.238A>G | p.Lys80Glu | missense_variant | 2/3 | XP_016884230.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C22orf31 | ENST00000216071.5 | c.361A>G | p.Lys121Glu | missense_variant | 2/3 | 1 | NM_015370.2 | ENSP00000216071.4 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251468Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135906
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461850Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 727224
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.361A>G (p.K121E) alteration is located in exon 2 (coding exon 2) of the C22orf31 gene. This alteration results from a A to G substitution at nucleotide position 361, causing the lysine (K) at amino acid position 121 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at